Aarti Pharmalabs Ltd share price logo

Aarti Pharmalabs Ltd Share Price (AARTIPHARM)

₹818.651.08%

as on

| Source : NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Aarti Pharmalabs Ltd Stock Performance

as on August 26, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹812.1
    ₹835
    downward going graph

    0.80%

    Downside

    2.00%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹557.05
    ₹971
    downward going graph

    31.96%

    Downside

    18.61%

    Upside

    downward going graph
Previous Close₹827.60
Open₹830.65
Volume4.04L
Upper Circuit₹993.10
Lower Circuit₹662.10
Day's Low812.1
Day's High835
52 Week Low557.05
52 Week High971
1 Month Return-11.3 %
3 Month Return-7.03 %
1 Year Return+ 24.92 %
3 Year Return+ 184.01 %
5 Year Return+ 184.01 %

Aarti Pharmalabs Ltd Stock Fundamentals & Key Indicators

Check Aarti Pharmalabs Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹7,419.80 Cr

Return on Equity (ROE)

13.11

PE Ratio (TTM)

27.85

Return on capital employed (ROCE)

16.4

Industry PE ratio

43.96

Beta (LTM)

0.91

P/B Ratio

2.43

Dividend Yield

0.69

PEG Ratio

6.13

Quarterly Earnings Growth YOY

-10.73

EPS (TTM)

23.93

Sector

Pharmaceuticals

Book Value

193.88

Technical Analysis

Aarti Pharmalabs Ltd Stock's Interest Amongst Investors

68.10%

Period Aug 28, 2025 to Jul 29, 2025. Change in 30 Days vs previous period

Investment in Aarti Pharmalabs Ltd Shares on INDmoney has grown by 68.10% over the past 30 days, indicating increased transactional activity.

31%

Period Aug 28, 2025 to Jul 29, 2025. Change in 30 Days vs previous period

Search interest for Aarti Pharmalabs Ltd Stock has increased by 31% in the last 30 days, reflecting an upward trend in search activity.

Aarti Pharmalabs Ltd Stock Valuation

Track how Aarti Pharmalabs Ltd P/E has moved over time to understand its valuation trends.

Aarti Pharmalabs Ltd in the last 5 years

  • Overview

  • Trends

Lowest (11.23x)

February 2, 2023

Today (27.85x)

August 26, 2025

Industry (43.96x)

August 26, 2025

Highest (32.82x)

July 16, 2025

LowHigh

Today’s Price to Earnings Ratio: 27.85x

Aarti Pharmalabs Ltd Financial Results

Get the annual and quarterly financial summary of Aarti Pharmalabs Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue

(in ₹ Cr)

555 (0%)458 (18%)538 (17%)564 (5%)386 (32%)
Net Income

(in ₹ Cr)

55 (0%)55 (2%)74 (35%)88 (19%)50 (44%)
Net Profit Margin9.98% (0%)11.92% (19%)13.76% (15%)15.67% (14%)12.82% (18%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

0 (0%)2040 (815864%)2246 (10%)2584 (15%)
Total Liabilities

(in ₹ Cr)

0 (0%)653 (3267050%)688 (5%)827 (20%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

-0 (0%)0 (100%)-65 (0%)216 (433%)184 (15%)

Aarti Pharmalabs Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Aarti Pharmalabs Ltd.

  • Aarti Pharmalabs Ltd Earnings Results

    Aarti Pharmalabs Ltd’s net profit fell -10.73% since last year same period to ₹49.50Cr in the Q1 2025-2026. On a quarterly growth basis, Aarti Pharmalabs Ltd has generated -43.97% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Aarti Pharmalabs Ltd Dividends February,2025

    In the quarter ending December 2024, Aarti Pharmalabs Ltd has declared dividend of ₹2.50 per share on 05 Feb 2025 - translating a dividend yield of 0.67%.

    Read More about Dividends

Indices Featuring Aarti Pharmalabs Ltd Stock

Check stock indices that include Aarti Pharmalabs Ltd.

BSE Healthcare

₹44,075.94

-1.65 (-739.95%)

BSE Small-Cap

₹52,097.59

-1.68 (-891.75%)

Aarti Pharmalabs Ltd Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Aarti Pharmalabs Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
43.72%
-1.28
Foreign Institutions
7.35%
-0.12
Mutual Funds
0.9%
15.04
Retail Investors
41.12%
0.77
Others
6.9%
2.12

Aarti Pharmalabs Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Aarti Pharmalabs Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA7,419.8036.8%0.572161,852
NA8.8139.65%0.00-11
NA31.22-5.34%0.001150
NA3,779.9664.71%0.7086806
HOLD31,756.801.19%0.536985,616

Aarti Pharmalabs Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Aarti Pharmalabs Ltd.

  • Aarti Pharmalabs Announces Dividend Record Date - 20 Aug, 2025

    Aarti Pharmalabs Ltd has announced September 15, 2025, as the record date for a final dividend of ₹2.5 per share for FY25.
  • Aarti Pharmalabs Reports Decline in Profit - 13 Aug, 2025

    Aarti Pharmalabs' consolidated net profit fell 10.73% to Rs 49.50 crore in Q1 FY26, with sales down 30.48% to Rs 386.19 crore. The company faces challenges despite a slight improvement in EBITDA margin.

Insights on Aarti Pharmalabs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 40.81% to 41.12% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.78% to 0.90% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 44.29% to 43.72% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, AARTIPHARM stock has moved down by -11.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 88.34 Cr → 49.5 Cr (in ₹), with an average decrease of 44.0% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 7.36% to 7.35% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 562.17 Cr → 387.79 Cr (in ₹), with an average decrease of 31.0% per quarter

About Aarti Pharmalabs Ltd

Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients API Pharmaceutical Intermediates New Chemical Entities NCE and Xanthine Derivatives situated in India.In 2001 the Company commissioned first API manufacturing Unit in Dombivali Unit 1 and started Xanthine Unit further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005 commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes MT per month in 2016. It expanded block for CSD Vapi and API Tarapur units in 2022.The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17 2022 and operational from July 1 2021. Pursuant to the said Demerger Scheme Aarti Industries Limited hived off its Pharmaceutical Division into a separate entity Aarti Pharmalabs Limited and accordingly all the assets and liabilities pertaining to the Pharma Business Undertaking got transferred and vested into the Company effective from the above said Date.Thereafter the Company in 2023 commercialised Block V at Tarapur Unit 4. Again it enhanced Xanthine capacity to 5000 TPA in 2023.90626008 Equity Shares of Rs 5/ each got listed effective January 30 2023..

Revenue: ₹386.19Cr as on June 2025 (Q1 FY26)
Net Profit: ₹49.50Cr as on June 2025 (Q1 FY26)
Listing date: 30 Jan, 2023
Chairperson Name: Rashesh C Gogri
OrganisationAarti Pharmalabs Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEORashesh C Gogri
E-voting on sharesClick here to vote

Mutual Funds that own Aarti Pharmalabs Ltd Stock

Check out the Mutual Funds with significant holdings in Aarti Pharmalabs Ltd.

FAQs

What is Aarti Pharmalabs Ltd share price today?

Aarti Pharmalabs Ltd share price today stands at ₹818.65, Open: ₹830.65, Previous Close: ₹827.6, High: ₹835, Low: ₹812.1, 52 Week High: ₹971, 52 Week Low: ₹557.05 as on .

How to buy Aarti Pharmalabs Ltd shares ?

To buy Aarti Pharmalabs Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AARTIPHARM or Aarti Pharmalabs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Aarti Pharmalabs Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of Aarti Pharmalabs Ltd?

Today's traded volume of Aarti Pharmalabs Ltd is 4.04L. Which means that 4.04L shares of Aarti Pharmalabs Ltd were bought and sold on the stock market during today's trading session.

What is Aarti Pharmalabs Ltd's market cap today?

Today's market capitalisation of Aarti Pharmalabs Ltd is ₹7,419.80 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Aarti Pharmalabs Ltd?

Aarti Pharmalabs Ltd’s 52 week high is ₹971 and 52 week low is ₹557.05. The current share price of Aarti Pharmalabs Ltd is ₹818.65, which is -15.69% down from its 52 week high and 46.96% up from its 52 week low.